ArticleBiomedicines2025

Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study.

Svenja Neuhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.